Renner U, Mojto J, Arzt E, Lange M, Stalla J, Müller O A, Stalla G K
Max-Planck-Institute of Psychiatry, Clinical Institute, University of Munich, FRG.
Neuroendocrinology. 1993 May;57(5):825-34. doi: 10.1159/000126441.
The growth-promoting activities of tumor-conditioned media (TU-CM) obtained from 23 cultured human nonfunctioning pituitary adenomas were studied in vitro. TU-CM obtained from adenoma cell cultures increased both cell counts (range: 108-179%; control = growth in serum-free medium = 100%) and 3H-thymidine incorporation (112-139%) of rat pituitary cell cultures, indicating that TU-CM contains growth-stimulating substances. TU-CM was also able to stimulate the growth of normal fibroblasts (3H-thymidine incorporation: 164-178%; cell counts: 145-157%) and endothelial cells (3H-thymidine incorporation: 131-149%; cell counts: 181-217%), suggesting the presence of - possibly angiogenic-growth factors that act on these cell types. However, the growth of hormone-producing cells was also stimulated, since TU-CM increased 3H-thymidine incorporation into rat pituitary cells in the presence of D-Val-MEM, a medium specifically inhibiting growth of fibroblasts. Addition of neutralizing antibodies against transforming growth factor alpha (TGF-alpha), epidermal growth factor (EGF), insulin-like growth factor I (IGF-I) and basic fibroblast growth factor (bFGF), either alone or in different combinations, reduced the growth-promoting activity of TU-CM on rat pituitary cells (range: 96-71%; control = growth effect of TU-CM without antibodies = 100%), strongly indicating the presence of these growth factors in TU-CM. All 4 antibodies together completely inhibited the growth-stimulatory activity of TU-CM, strongly suggesting that these growth factors play the major role among growth-stimulating substances in TU-CM. This is the first study giving evidence that TGF-alpha, EGF, IGF-I and bFGF are secreted by nonfunctioning adenoma cells indicating that the growth factors could be involved in growth regulation of pituitary adenomas by paracrine or autocrine mechanisms.
对从23例培养的人类无功能垂体腺瘤中获得的肿瘤条件培养基(TU-CM)的促生长活性进行了体外研究。从腺瘤细胞培养物中获得的TU-CM增加了大鼠垂体细胞培养物的细胞计数(范围:108 - 179%;对照 = 在无血清培养基中的生长 = 100%)和3H-胸腺嘧啶核苷掺入量(112 - 139%),表明TU-CM含有生长刺激物质。TU-CM还能够刺激正常成纤维细胞(3H-胸腺嘧啶核苷掺入量:164 - 178%;细胞计数:145 - 157%)和内皮细胞(3H-胸腺嘧啶核苷掺入量:131 - 149%;细胞计数:181 - 217%)的生长,提示存在可能作用于这些细胞类型的血管生成生长因子。然而,产生激素的细胞的生长也受到了刺激,因为在存在特异性抑制成纤维细胞生长的培养基D-Val-MEM的情况下,TU-CM增加了大鼠垂体细胞中3H-胸腺嘧啶核苷的掺入。单独或不同组合添加针对转化生长因子α(TGF-α)、表皮生长因子(EGF)、胰岛素样生长因子I(IGF-I)和碱性成纤维细胞生长因子(bFGF)的中和抗体,降低了TU-CM对大鼠垂体细胞的促生长活性(范围:96 - 71%;对照 = 无抗体时TU-CM的生长效应 = 100%),强烈表明TU-CM中存在这些生长因子。所有4种抗体一起完全抑制了TU-CM的生长刺激活性,强烈提示这些生长因子在TU-CM中的生长刺激物质中起主要作用。这是第一项提供证据表明TGF-α、EGF、IGF-I和bFGF由无功能腺瘤细胞分泌的研究,表明这些生长因子可能通过旁分泌或自分泌机制参与垂体腺瘤的生长调节。